Nine Monthly Results Results Snapshot
Figures in Rs cr
Standalone Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 24.81% vs 17.85% in Dec 2023
Standalone Net Profit
YoY Growth in nine months ended Dec 2024 is 30.02% vs 39.68% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 35.89% vs 54.09% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is 53.23% vs 62.24% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
Compare Nine Monthly Results Of Fredun Pharma With
Figures in Rs cr
Standalone Nine Monthly Results
Change(INR)
Change(%)
Net Sales
286.27
7,329.57
-7,043.30
-96.09%
Other Operating Income
2.60
0.00
2.60
Total Operating income
288.87
7,329.57
-7,040.70
-96.06%
Raw Material Cost
198.97
566.08
-367.11
-64.85%
Purchase of Finished goods
0.00
1,433.87
-1,433.87
-100.00%
(Increase) / Decrease In Stocks
7.28
49.31
-42.03
-85.24%
Employee Cost
12.53
1,569.75
-1,557.22
-99.20%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
12.98
0.00
12.98
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
19.44
1,645.40
-1,625.96
-98.82%
Total Expenditure (Excl Depreciation)
251.20
5,264.41
-5,013.21
-95.23%
Operating Profit (PBDIT) excl Other Income
37.67
2,065.16
-2,027.49
-98.18%
Other Income
0.00
270.41
-270.41
-100.00%
Operating Profit (PBDIT)
37.67
2,335.57
-2,297.90
-98.39%
Interest
14.22
207.65
-193.43
-93.15%
Exceptional Items
0.00
61.23
-61.23
-100.00%
Gross Profit (PBDT)
23.45
2,127.92
-2,104.47
-98.90%
Depreciation
3.20
255.85
-252.65
-98.75%
Profit Before Tax
20.23
1,872.07
-1,851.84
-98.92%
Tax
6.49
369.00
-362.51
-98.24%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
13.73
1,503.07
-1,489.34
-99.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
13.73
1,564.30
-1,550.57
-99.12%
Equity Capital
4.72
40.06
-35.34
-88.22%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
13.04%
28.18%
0.00
-15.14%
Gross Profit Margin
8.12%
29.03%
0.00
-20.91%
Public Share Holdings (%)
51.07%
0.00%
51.07
51.07%
Nine Monthly - Net Sales
Net Sales 286.27 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 24.81% vs 17.85% in Dec 2023
Nine Monthly - Standalone Net Profit
Standalone Net Profit 13.73 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 30.02% vs 39.68% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.67 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 35.89% vs 54.09% in Dec 2023
Nine Monthly - Interest
Interest 14.22 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 53.23% vs 62.24% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.04%
in Dec 2024Figures in Rs %
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
